Dental Care Clinics in Susanville, CA Accepting Medicare
4 Dental Care Clinics found. Showing 1 - 4
 Susanville Dental Care Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 720 Ash St, Susanville, CA 96130 Phone: 530-257-7256 Fax: 530-257-3546 |
Smiles For Life, Inc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 1803 First Street, Susanville, CA 96130 Phone: 530-257-9640 Fax: 530-257-9640 |
Susanville Orthodontic Care Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 720 Ash St Ste A, Susanville, CA 96130 Phone: 530-257-4455 |
Sean P. Buehler, Dds, Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1408 Main St, Susanville, CA 96130 Phone: 530-257-3300 Fax: 530-257-3322 |
News Archive
Fetal gut has more well-developed immune capabilities than previously thought
Most biology textbooks explain that the fetal immune system is largely undeveloped and that it learns after being exposed to the world at birth. New research from the University of Pittsburgh School of Medicine and UPMC Children's Hospital of Pittsburgh challenges that paradigm, and provides the first comprehensive look at the immune system of the developing gut.
Compulsively checking social media could be hurting our brain
You know that warm feeling you get when you see lots of likes from a Facebook or Instagram post? That's the reward system of your brain lighting up like fireflies on a dark summer night.
CHMP recommends approval of Xofigo for CRPC, symptomatic bone and visceral metastases
Bayer HealthCare announced today that the the European Committee for Medicinal Products for Human Use recommended Xofigo (radium Ra 223 dichloride) for approval with a proposed indication for the treatment of adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases.
Cardiome signs commercialization agreement with AOP for ESMOCARD products
Cardiome Pharma Corp. today announced that the company has entered a commercialization agreement with AOP Orphan Pharma to sell AOP's cardiovascular products, ESMOCARD and ESMOCARD LYO (esmolol hydrochloride) in Italy, France, Spain and Belgium.
Study focuses on genetic neurological disorders that develop in children over time
A team of researchers at Children's Hospital of Philadelphia (CHOP) affiliated with the CHOP Epilepsy Neurogenetics Initiative (ENGIN) further bridged the gap between genomic information and clinical outcome data by systematically linking genetic information with electronic medical records, focusing on how genetic neurological disorders in children develop over time.
› Verified 3 days ago